High-intensity training (HIT) has repeatedly been documented to have superior positive effects compared to moderate exercise in patients with coronary heart disease and heart failure. Since heart transplant recipients (HTx), have a denervated heart with different respond to exercise, HIT has previously not been introduced among these patients. Rikshospitalet carried out a RCT to investigate this (the TEX study 2009-2012), and found that this form of exercise also was highly effective and safe in long term HTx with clinically significant improvement in VO2peak, muscular exercise capasity, general HRQoL, and even slower progression of CAV (coronary allograft vasculopathy). Based on these findings we ask the following questions in this follow-up study: 1. Would the effect on VO2peak, HRQoL,muscle capacity and CAV obtained during the study period continue during long term follow up (5 years)? 2. Is the intervention group more physical active after HIT compared to the control group?
Study Type
OBSERVATIONAL
Enrollment
41
OUS- Rikshospitalet
Oslo, Oslo County, Norway
mean VO2peak in the intervention group and control group
We will use the same test protocol as the TEX- study.
Time frame: 5 years after start of inclusion in RCT (TEX). One measurment.
How many has progression of cardiac allograft vasculopathy in the intervention group and control group.
Progression of vasculopathy will be studied with IVUS technique, and compared with IVUS pictures from TEX.
Time frame: 5 years after inclusion in RCT (TEX study).
Mean muscle capacity in the intervention group and control group.
Time frame: 5 years after inclusion in RCT, TEX study.
Quality of life
We will use validated questionnaires to estimate quality of life and to evaluate depression.
Time frame: 5 years after inclusion in TEX- study.
Difference in activity level between groups
To estimate activity the study population will fill out a validated questionnaire about physical activity, and they will wear a physical activity monitor at home for one week.
Time frame: 5 years after inclusion i RCT, TEX study.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.